These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 28315622)
21. 2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population. Cho YK; Jung CH; Kang YM; Hwang JY; Kim EH; Yang DH; Kang JW; Park JY; Kim HK; Lee WJ J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543305 [TBL] [Abstract][Full Text] [Related]
22. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA. Mortensen MB; Falk E; Li D; Nasir K; Blaha MJ; Sandfort V; Rodriguez CJ; Ouyang P; Budoff M JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):221-230. PubMed ID: 28624395 [TBL] [Abstract][Full Text] [Related]
23. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004 [TBL] [Abstract][Full Text] [Related]
24. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960 [TBL] [Abstract][Full Text] [Related]
25. Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging. Razavi AC; Kelly TN; Budoff MJ; Bazzano LA; He J; Fernandez C; Lima J; Nasir K; Blumenthal RS; Blaha MJ; Whelton SP Atherosclerosis; 2021 Jun; 326():56-62. PubMed ID: 33824003 [TBL] [Abstract][Full Text] [Related]
26. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy. Mortensen MB; Afzal S; Nordestgaard BG; Falk E J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease. Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056 [TBL] [Abstract][Full Text] [Related]
28. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Al Rifai M; Yao J; Guo X; Post WS; Malik S; Blumenthal RS; Ballantyne CM; Budoff M; Taylor KD; Lin HJ; Rich SS; Hajek C; Greenland P; Rotter JI; Virani SS Prog Cardiovasc Dis; 2022; 74():19-27. PubMed ID: 35952728 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population. Mortensen MB; Nordestgaard BG Ann Intern Med; 2018 Jan; 168(2):85-92. PubMed ID: 29297004 [TBL] [Abstract][Full Text] [Related]
30. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease. Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372 [TBL] [Abstract][Full Text] [Related]
31. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729 [TBL] [Abstract][Full Text] [Related]
32. The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography. Pursnani A; Mayrhofer T; Ferencik M; Hoffmann U Atherosclerosis; 2014 Nov; 237(1):314-8. PubMed ID: 25299966 [TBL] [Abstract][Full Text] [Related]
33. CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular Disease. Cainzos-Achirica M; Quispe R; Dudum R; Greenland P; Lloyd-Jones D; Rana JS; Lima JAC; Doria de Vasconcellos H; Joshi PH; Khera A; Ayers C; Erbel R; Stang A; Jöckel KH; Lehmann N; Schramm S; Schmidt B; Toth PP; Patel KV; Blaha MJ; Bittencourt M; Nasir K JACC Cardiovasc Imaging; 2022 Apr; 15(4):641-651. PubMed ID: 34922873 [TBL] [Abstract][Full Text] [Related]
34. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study. Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545 [TBL] [Abstract][Full Text] [Related]
35. Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease. Naami R; Tashtish N; Neeland IJ; Katz J; Sinh P; Nasir K; Chittajallu V; Mansoor E; Rajagopalan S; Al-Kindi S Am Heart J; 2023 Dec; 266():120-127. PubMed ID: 37634654 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. Tailor TD; Chiles C; Yeboah J; Rivera MP; Tong BC; Schwartz FR; Benefield T; Lane LM; Stashko I; Thomas SM; Henderson LM J Am Coll Radiol; 2021 Sep; 18(9):1258-1266. PubMed ID: 33640340 [TBL] [Abstract][Full Text] [Related]
37. Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations. Anderson TS; Wilson LM; Sussman JB JAMA Intern Med; 2024 Aug; 184(8):963-970. PubMed ID: 38856978 [TBL] [Abstract][Full Text] [Related]
38. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts. Akintoye E; Afonso L; Bengaluru Jayanna M; Bao W; Briasoulis A; Robinson J J Am Heart Assoc; 2021 Jun; 10(12):e019589. PubMed ID: 34092110 [TBL] [Abstract][Full Text] [Related]
39. Nonobstructive Coronary Artery Disease by Coronary CT Angiography Improves Risk Stratification and Allocation of Statin Therapy. Emami H; Takx RAP; Mayrhofer T; Janjua S; Park J; Pursnani A; Tawakol A; Lu MT; Ferencik M; Hoffmann U JACC Cardiovasc Imaging; 2017 Sep; 10(9):1031-1038. PubMed ID: 28330658 [TBL] [Abstract][Full Text] [Related]
40. Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults. Han D; Ó Hartaigh B; Lee JH; Rizvi A; Park HE; Choi SY; Sung J; Chang HJ Yonsei Med J; 2017 Jan; 58(1):82-89. PubMed ID: 27873499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]